FDA Must Protect Women and Children From Dangerous Abortion Drugs

Liberty Counsel filed an amicus brief to the U.S. Fifth Circuit Court of Appeals in Louisiana v. FDA, a case seeking to reinstate the in-person dispensing requirement for the chemical abortion drug Mifepristone. In 2023, the U.S. Food and Drug Administration loosened safety regulations allowing the dangerous drug to be distributed through the mail without in-person medical supervision. Liberty Counsel […]

The post FDA Must Protect Women and Children From Dangerous Abortion Drugs appeared first on LifeNews.com.